Pevec, D., Novinscak, T., Brcic, L., Sipos, K., Jukic, I., Staresinic, M., Mise, S., Brcic, I., Kolenc, D., Klicek, R., Banic, T., Sever, M., Kocijan, A., Berkopic, L., Radic, B., Buljat, G., Anic, T., Zoricic, I., Bojanic, I., Sikiric, P
NCCN will soon add a second patient guideline on another type of immunotherapy: chimeric antigen receptor (CAR) T-cell therapy
Bakacak M, Kln M, Serin S, et al
[7] Another aspect is that MB, in high IV doses, can paradoxically cause methemoglobinemia because it can auto-oxidize at excessive concentrations
[1] Mechanistically it works along a single hormonal pathway the amylin system which is what distinguishes it from the multi-receptor incretin agonists it is often compared with